Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
213.00    0.00 (0.00%)
Bid:
211.00
Ask:
215.00
Spread: 4.00 (1.896%)
Market Cap: £145.42m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Directorate Change

7 Jun 2024 07:00

RNS Number : 4982R
Helios Underwriting Plc
07 June 2024
 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

 

Helios Underwriting plc

("Helios", "the Group" or "the Company")

 

Directorate Change

 

07 June 2024

 

Helios, the only publicly traded investment company offering instant access to a diverse portfolio at Lloyd's of London, the world's largest insurance market, today announces that Martin Reith has stepped down from his role as Chief Executive Officer, to pursue other opportunities. 

 

Michael Wade, currently Non-Executive Chairman, will become Executive Chairman with immediate effect as the search for Martin's successor begins. Nigel Hanbury, currently Executive Deputy Chairman, will become Non-Executive Deputy Chairman.

 

Helios recently reported a significant rise in profits and distributions in its full year 2024 results. The Company reported doubling of the capacity over the last two years of its Lloyd's syndicate portfolio to £507m for 2024, underlining its strategy and commitment as a manager of its spread on the 2024 year of account, where the Company has a retained proportion of 77%.The Company reiterated its intention to continue to act for third-party capital providers and anticipates this will grow as a proportion into 2025.

 

Following recent press speculation, the Board can confirm that it has explored the potential of establishing a new 'follow only' syndicate at Lloyd's, but it has decided not to pursue this concept in order to focus exclusively on supporting its spread portfolio.

 

Michael Wade, Executive Chairman of Helios, commented:

 

"Martin has made a significant contribution to Helios and has been instrumental in developing the Helios spread syndicate portfolio, accelerating the performance of the Company and growing our in-house management team. We wish him the very best for the future."

 

For further information, please contact:

 

Helios Underwriting plc

 

Michael Wade - Executive Chairman  Michael.Wade@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)203 965 6441

Deutsche Numis (Nomad and Broker)

 

Giles Rolls / Charles Farquhar

+44 (0)20 7260 1000

 

FTI Consulting

 

Ed Berry / Tom O'Brien

+44 (0)7703 330 199 / +44 (0)7929 021 492

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £507m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZZGGVGVNGDZZ
Date   Source Headline
30th Aug 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
29th Aug 202312:30 pmRNSTransaction in Own Shares
25th Aug 20232:12 pmRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in own shares
23rd Aug 202311:44 amRNSShare Repurchase Programme
21st Aug 20234:23 pmRNSNotification of Major Holdings
21st Aug 202311:40 amRNSDirector's Shareholding
18th Aug 20238:22 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20234:30 pmRNSShare Repurchase Programme
2nd Aug 20237:00 amRNSTotal Voting Rights
25th Jul 20237:00 amRNSAcquisition
14th Jul 20237:00 amRNSDirector Dealing
14th Jul 20237:00 amRNSAcquisition of Limited Liability Vehicle
13th Jul 20237:00 amRNSIssue of Equity
4th Jul 20237:00 amRNSResults of Scrip Dividend Election
29th Jun 20233:46 pmRNSDirectorship Change
29th Jun 202311:27 amRNSResults of Annual General Meeting
29th Jun 20237:00 amRNSNotification of Major Holdings
16th Jun 20237:00 amRNSScrip Dividend Reference Price
7th Jun 20233:53 pmRNSDirector’s Shareholding
5th Jun 20233:39 pmRNSFinal Dividend Timetable
5th Jun 20237:00 amRNSDirector’s/PCA Shareholdings
1st Jun 20237:00 amRNSGrant of LTIP Award
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
31st May 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
26th May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSChange of Adviser
11th May 20237:00 amRNSDirectors' Disclosure
11th Apr 20237:00 amRNSDirector's/PCAs' Shareholding
5th Apr 20237:00 amRNSGrant of LTIP Award and Director Dealing
5th Apr 20237:00 amRNSDirector/PCA Shareholdings
4th Apr 20237:00 amRNSDirectorate Change
4th Apr 20237:00 amRNSQuarterly Syndicate Mid Point Forecasts
10th Jan 20237:00 amRNS2023 Helios Retained Capacity Update
29th Dec 20223:38 pmRNSAcquisitions of LLVs, Issue of Equity and TVR
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 202212:06 pmRNSHolding(s) in Company
19th Dec 20229:07 amRNSGrant of LTIP Awards and Directors' Dealings
14th Dec 202212:47 pmRNSHolding(s) in Company
13th Dec 202211:29 amRNSResult of GM, TVR and Directors' Participation
12th Dec 20227:00 amRNSResult of Open Offer
24th Nov 202212:54 pmRNSReplacement - Result of Placing and Subscription
24th Nov 20227:00 amRNSResult of Placing and Subscription
23rd Nov 20224:45 pmRNSFundraising to raise up to approximately £13.5m
29th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSQuarterly Syndicate Mid Point Forecasts
29th Jun 20221:13 pmRNSResult of AGM
1st Jun 20222:31 pmRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.